eMedicine Specialties > Ophthalmology > Conjunctiva

Filtering Bleb Complications

Carlo E Traverso, MD, Associate Professor, University Eye Clinic, Genova; Consulting Staff and Head of Glaucoma and Cornea Clinical Unit, University of Genova Medical School, Italy
Contributor Information and Disclosures

Updated: Jul 18, 2007

Introduction

Background

The consequences of bleb-associated complications include the following, listed in order of potential morbidity: predisposition to or cause of infection, unsatisfactory bleb function (ie, intraocular pressure [IOP] too low, IOP too high), dysesthesia, decreased visual acuity, and/or loss of the globe, which can be the final outcome.

Pathophysiology

The goal of glaucoma filtering surgery is to reduce IOP with surgery. The pressure can be too high or too low following the surgery.

Frequency

United States

Uncommon

Mortality/Morbidity

Bleb complications can be classified according to their vision-threatening potential and impact on quality of life.

All bleb-related complications have infection/endophthalmitis as a possible consequence, with high morbidity. Also, bleb failure with consequent rise in IOP is a possible consequence.

The cost for the individual and the community in terms of discomfort, unplanned care, loss of work time, direct medical expenses, and decrease in visual function cannot be estimated and may be high.

Race

No racial predisposition exists.

Sex

No sexual influence exists.

Age

No influence of age exists.

Clinical

History

History includes previous filtration surgery for the management of glaucoma. Presentation varies remarkably depending on the complication being observed.

Physical

Clinical picture varies considerably depending on the complication. These eyes show evidence of filtration surgery in common, with a range of associated glaucomatous damage.

Causes

  • Buttonholes and tears, dehiscence, or retraction

    • Conjunctival buttonholes and tears, dehiscence, or retraction of the conjunctival incision are usually a result of suboptimal surgical techniques.
    • Care must be taken in handling the tissues, and meticulous suturing techniques need to be used. Attention to detail is key in the prevention of these problems.
    • Dehiscence and retraction are almost unavoidable when using absorbable sutures in conjunction with antimetabolites. 
    • Each of the above events can cause an entire spectrum of bleb-associated complications (see Complications).
  • The most evident risk factor for late bleb leaks, bleb ruptures, and infections is the intraoperative or postoperative use of antimetabolites. After antimetabolites, blebs tend to be more ischemic and thinner, with progressive thinning and possible spontaneous rupture.

Contents

Overview: Filtering Bleb Complications
Differential Diagnoses & Workup: Filtering Bleb Complications
Treatment & Medication: Filtering Bleb Complications
Follow-up: Filtering Bleb Complications
Multimedia: Filtering Bleb Complications

References

  1. Azuara-Blanco A, Katz LJ. Dysfunctional filtering blebs. Surv Ophthalmol. Sep-Oct 1998;43(2):93-126. [Medline].

  2. Busbee BG, Recchia FM, Kaiser R, Nagra P, Rosenblatt B, Pearlman RB. Bleb-associated endophthalmitis: clinical characteristics and visual outcomes. Ophthalmology. Aug 2004;111(8):1495-503; discussion 1503. [Medline].

  3. Fluorouracil Filtering Surgery Study Group. Five-year follow-up of the Fluorouracil Filtering Surgery Study. Am J Ophthalmol. Apr 1996;121(4):349-66. [Medline].

  4. Halkiadakis I, Lim P, Moroi SE. Surgical results of bleb revision with scleral patch graft for late-onset bleb complications. Ophthalmic Surg Lasers Imaging. Jan-Feb 2005;36(1):14-23. [Medline].

  5. Higginbotham EJ, Stevens RK, Musch DC, Karp KO, Lichter PR, Bergstrom TJ, et al. Bleb-related endophthalmitis after trabeculectomy with mitomycin C. Ophthalmology. Apr 1996;103(4):650-6. [Medline].

  6. Hu CY, Matsuo H, Tomita G, Suzuki Y, Araie M, Shirato S, et al. Clinical characteristics and leakage of functioning blebs after trabeculectomy with mitomycin-C in primary glaucoma patients. Ophthalmology. Feb 2003;110(2):345-52. [Medline].

  7. Jonas JB, Dugrillon A, Kluter H, Kamppeter B. Subconjunctival injection of autologous platelet concentrate in the treatment of overfiltrating bleb. J Glaucoma. Feb 2003;12(1):57-8. [Medline].

  8. Kangas TA, Greenfield DS, Flynn HW, Parrish RK, Palmberg P. Delayed-onset endophthalmitis associated with conjunctival filtering blebs. Ophthalmology. May 1997;104(5):746-52. [Medline].

  9. Mochizuki K, Jikihara S, Ando Y, Hori N, Yamamoto T, Kitazawa Y. Incidence of delayed onset infection after trabeculectomy with adjunctive mitomycin C or 5-fluorouracil treatment. Br J Ophthalmol. Oct 1997;81(10):877-83. [Medline].

  10. Parrish R, Minckler D. "Late endophthalmitis"--filtering surgery time bomb?. Ophthalmology. Aug 1996;103(8):1167-8. [Medline].

  11. Sony P, Kumar H, Pushker N. Treatment of overhanging blebs with frequency-doubled Nd:YAG laser. Ophthalmic Surg Lasers Imaging. Sep-Oct 2004;35(5):429-32. [Medline].

  12. Tannenbaum DP, Hoffman D, Greaney MJ, Caprioli J. Outcomes of bleb excision and conjunctival advancement for leaking or hypotonous eyes after glaucoma filtering surgery. Br J Ophthalmol. Jan 2004;88(1):99-103. [Medline].

  13. Wolner B, Liebmann JM, Sassani JW, Ritch R, Speaker M, Marmor M. Late bleb-related endophthalmitis after trabeculectomy with adjunctive 5-fluorouracil. Ophthalmology. Jul 1991;98(7):1053-60. [Medline].

  14. Yarangumeli A, Koz OG, Kural G. Encapsulated blebs following primary standard trabeculectomy: course and treatment. J Glaucoma. Jun 2004;13(3):251-5. [Medline].

Further Reading

Keywords

buttonhole, tear, dehiscence, retraction, infection, blebitis, endophthalmitis, leakage, dysesthesia, encapsulated bleb, failing bleb, glaucoma

Contributor Information and Disclosures

Author

Carlo E Traverso, MD, Associate Professor, University Eye Clinic, Genova; Consulting Staff and Head of Glaucoma and Cornea Clinical Unit, University of Genova Medical School, Italy
Carlo E Traverso, MD is a member of the following medical societies: American Academy of Ophthalmology, Association for Research in Vision and Ophthalmology, and European Glaucoma Society
Disclosure: Nothing to disclose

Medical Editor

Neil T Choplin, MD, Adjunct Clinical Professor, Department of Surgery, Section of Ophthalmology, Uniformed Services University of Health Sciences
Neil T Choplin, MD is a member of the following medical societies: American Academy of Ophthalmology, American Glaucoma Society, Association for Research in Vision and Ophthalmology, and California Medical Association
Disclosure: Nothing to disclose

Pharmacy Editor

Simon K Law, MD, PharmD, Assistant Professor of Ophthalmology, Jules Stein Eye Institute; Chief of Section of Ophthalmology Surgical Services, Department of Veterans Affairs Healthcare Center, West Los Angeles
Simon K Law, MD, PharmD is a member of the following medical societies: American Academy of Ophthalmology, American Glaucoma Society, and Association for Research in Vision and Ophthalmology
Disclosure: Nothing to disclose

Managing Editor

J James Rowsey, MD, Former Director of Corneal Services, St Luke's Cataract and Laser Institute, Florida
J James Rowsey, MD is a member of the following medical societies: American Academy of Ophthalmology, American Association for the Advancement of Science, American Medical Association, Association for Research in Vision and Ophthalmology, Florida Medical Association, Pan-American Association of Ophthalmology, Sigma Xi, and Southern Medical Association
Disclosure: Nothing to disclose

CME Editor

Lance L Brown, OD, MD, Ophthalmologist, Affiliated With Freeman Hospital and St John's Hospital, Regional Eye Center, Joplin, Missouri
Disclosure: Nothing to disclose

Chief Editor

Hampton Roy Sr, MD, Associate Clinical Professor, Department of Ophthalmology, University of Arkansas for Medical Sciences
Hampton Roy Sr, MD is a member of the following medical societies: American Academy of Ophthalmology, American College of Surgeons, and Pan-American Association of Ophthalmology
Disclosure: Nothing to disclose

Related eMedicine Articles
 
 
HONcode

We subscribe to the
HONcode principles of the
Health On the Net Foundation

All material on this website is protected by copyright, Copyright© 1994- by Medscape.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.